A new report by Fuel3D, a leading provider of 3D capture and measurement solutions, reveals that poor fitting eyewear is costing opticians and eyewear retailers more than US$26 billion a year. Fuel3D’s study, which looks at the importance of fit on buyer experience in the...
Have you ever struggled to find a pair of glasses or sunglasses that fit you properly or that really suit you? Faced with a bewildering choice of frames in-store and online, it can be hard to know where to start. That’s soon to change with our...
Post by: Karl Turley, CMO of Fuel3D What could be more unique and personal than a pair of sunglasses made just for you? That’s what we did for the four lucky winners of our ‘Does your face fit?’ competition which we ran in the Future Lab...
Post by: Karl Turley, CMO As part of the latest evolution of BioVolume we have produced a VR workflow demonstration. This way, we’re able to easily showcase the solution end-to-end without the need to access a laboratory. The experience gives us the freedom to demonstrate just about...
Post by: Andrew Smith, Head of BioVolume Commercialisation During the past few weeks we’ve been busy unveiling the latest evolution of our BioVolume subcutaneous tumour monitoring solution in Europe and the US. Combining 3D imaging with thermography, BioVolume is setting a new standard in the quest...
Earlier this month, we held a breakfast briefing at the NCRI Cancer Conference in Glasgow – see a recording of presentation given by Andrew Smith (BioVolume Commercialisation Lead) and Juan Delgado PhD (Lead Data Scientist) here: In summary, the talk concentrates on the following 3 themes: -...
2 November 2018 Fuel3D, a world-leading 3D technology innovator, will be showcasing for the first time in the UK, its newly updated ground-breaking BioVolume subcutaneous tumour monitoring solution at the 2018 NCRI Cancer Conference. BioVolume is the only solution in the market that combines the use...
24th October 2018 Fuel3D, a world-leading 3D technology innovator will be unveiling its updated BioVolume subcutaneous tumour monitoring solution at the AALAS National Meeting. This new BioVolume solution is the world’s first to combine the use of 3D imaging with thermography to monitor disease progression and...
Post by: George Thaw, CEO at Fuel3D The 'reproducibility crisis' in the life sciences continues to make headlines. Research shows that more than 50% of published studies cannot be reproduced[1], while some experts believe the number could be significantly higher. In a recent Nature survey[2],...
Karl Turley, CMO at Fuel3D The face of retail is changing. Digital innovation is shaping the future, and rewriting the rulebook for traditional high street retailers who are being forced to reinvent themselves in a digital age. Customer experience has become the new battleground and...
